WBA:NSD-Walgreens Boots Alliance Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 8.52

Change

+0.27 (+3.27)%

Market Cap

USD 7.52B

Volume

0.02B

Analyst Target

USD 42.72
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
HITI High Tide Inc

-0.05 (-2.50%)

USD 0.17B
PETS PetMed Express Inc

+0.09 (+2.54%)

USD 0.07B
MEDS Trxade Group Inc

-0.42 (-5.61%)

USD 0.01B
CJJD China Jo-Jo Drugstores Inc

+0.09 (+5.63%)

USD 0.01B
LFLYW Leafly Holdings Inc

N/A

N/A
MDVLQ MedAvail Holdings Inc

N/A

N/A

ETFs Containing WBA

FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FMK 0.00 % 0.70 %

N/A

N/A
IBDK 0.00 % 0.10 %

N/A

N/A
IVFVC 0.00 % 0.00 %

N/A

N/A
DWSH AdvisorShares Dorsey Wrig.. 0.00 % 0.00 %

-0.17 (0%)

USD 0.01B
FCW:CA 0.00 % 0.90 %

N/A

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
GBDV 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -67.37% 17% F 10% F
Dividend Return 2.87% 100% F 61% D-
Total Return -64.50% 17% F 11% F
Trailing 12 Months  
Capital Gain -59.23% 50% F 14% F
Dividend Return 5.89% 100% F 75% C
Total Return -53.35% 50% F 17% F
Trailing 5 Years  
Capital Gain -84.34% 67% D+ 14% F
Dividend Return 16.14% 50% F 66% D+
Total Return -68.20% 67% D+ 19% F
Average Annual (5 Year Horizon)  
Capital Gain -17.88% 83% B 18% F
Dividend Return -13.58% 83% B 22% F
Total Return 4.31% 100% F 80% B-
Risk Return Profile  
Volatility (Standard Deviation) 26.21% 100% F 68% D+
Risk Adjusted Return -51.81% 50% F 17% F
Market Capitalization 7.52B 100% F 91% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.